[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 346
Citations 0
Letters
February 27, 2013

Prognostic Assay in Small, Node-Negative Non–Small Cell Lung Cancer

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Department of Thoracic Surgery, Sapienza University of Rome, Rome, Italy (marcoanile75@gmail.com).

JAMA. 2013;309(8):769-770. doi:10.1001/jama.2012.211724

To the Editor: Dr Kratz and colleagues1 suggested that the use of a new molecular assay could affect prognosis and therapeutic strategy in patients with small, node-negative non–small cell lung cancer (NSCLC). This assay has been previously validated by the same authors in an international population with nonsquamous NSCLC.2 Some points about the results need to be considered.

First Page Preview View Large
First page PDF preview
First page PDF preview
×